Christopher Windham M.D. - Surgical Oncology
Practice: 224 Memorial Medical Parkway
Mailing: 301 Memorial Medical Parkway
Daytona Beach, FL 32117
ph: 386-231-4000
fax: 386-231-4001
TChristo
International, National, and Regional Presentations/ Visiting Lectures:
"Gastric Cancer in the Young: Does Delay in Diagnosis Affect Survival?" Presented at The American College of Surgeons South Texas Chapter Annual Meeting, 1997.
"Decreased Expression of c-Src in Human Colon Cancer HT29 Cells Increases Intrinsic and Staurosporine Induced Apoptosis." Presented at The University of Texas M.D. Anderson Cancer Center 1st Annual Symposium on Fundamental Cancer Research Molecular Targets for Cancer Therapy and Prevention, 1998.
"Decreased Expression of c-Src in Human Colon Cancer HT29 Cells Increases Intrinsic and Staurosporine Induced Apoptosis." Presented at The University of Texas M.D. Anderson Cancer Center Biologic Principles for the Therapy of Human Colon Cancer, 1998.
"Decreased Expression of c-Src in Human Colon Cancer HT29 Cells Results in Increased Intrinsic and Staurosporine Induced Apoptosis." Presented atthe60th Annual Meeting of The Society of University Surgeons, 1999.
"Decreased Expression of c-Src in Human Colon Cancer HT29 Cells Results in Increased Intrinsic and Staurosporine Induced Apoptosis."Presented at the Annual Meeting of The American College of Surgeons South Texas Chapter, 1999.
"Gastric Cancer in the Young: Does Delay in Diagnosis Affect Survival?" Presented at The American College of Surgeons South Texas Chapter Annual Meeting, 1997.
"Decreased Expression of c-Src in Human Colon Cancer HT29 Cells Increases Intrinsic and Staurosporine Induced Apoptosis." Presented at The University of Texas M.D. Anderson Cancer Center 1st Annual Symposium on Fundamental Cancer Research Molecular Targets for Cancer Therapy and Prevention, 1998.
"Decreased Expression of c-Src in Human Colon Cancer HT29 Cells Increases Intrinsic and Staurosporine Induced Apoptosis." Presented at The University of Texas M.D. Anderson Cancer Center Biologic Principles for the Therapy of Human Colon Cancer, 1998.
"Decreased Expression of c-Src in Human Colon Cancer HT29 Cells Results in Increased Intrinsic and Staurosporine Induced Apoptosis." Presented atthe60th Annual Meeting of The Society of University Surgeons, 1999.
"Decreased Expression of c-Src in Human Colon Cancer HT29 Cells Results in Increased Intrinsic and Staurosporine Induced Apoptosis."Presented at the Annual Meeting of The American College of Surgeons South Chapter, 1999.
"FAK Degradation and Apoptosis Increase in a Human Colon Cancer Cell Line with Decreased c-Src Expression." Presented at the 52nd Annual Meeting of The Society of Surgical Oncology Cancer Symposium, 1999.
"c-Src Activity Inhibits Apoptosis in Human Adenocarcinoma HT29 Cells Through a FAK-Mediated Pathway." Presented at The American College of Surgeons 1999 Clinical Congress Surgical Forum, 1999.
“Recurrent Well-Differentiated Thyroid Cancer.” Grand Rounds- The University of Texas-Houston, Department of Surgery, 2002.
“STAT3 Activation in Sarcomas.” Presented at the Ninth Annual Meeting of The Connective Tissue Oncology Society, 2003.
“STAT3 Activation in Sarcomas.” Presented at the Joint Cancer Conference of the Florida Universities, 2004.
“Soft Tissue Sarcomas and Retroperitoneal Disease.” Presented at the Joint Cancer Conference of the Florida Universities, 2004.
“Management of Bone and Soft Tissue Sarcomas.” Presented at the Sarasota Orthopedic Group, 2004.
“Management of Soft Tissue Sarcomas.” Presented at the Bradenton Orthopedic Group, 2004.
“Current Status of Soft Tissue Sarcoma-Molecular and Clinical Overview.” Presented at the Sarcoma Research Forum-H. Lee Moffitt Cancer Center & Research Institute, 2004.
“Fibrous and Vascular Tumors.” Presented at The Musculoskeletal Oncology Review. June 2004.
"Application of Linear Cutting Staplers in Resection of Soft Tissue Tumors." Presentated at the Musculoskeletal Tumor Society Meeting, 2004.
“PDGF-R alpha Expression and Activation in Human Sarcoma.” Presented at the Joint Cancer Conference of the Florida Universities. January 2005.
“Soft Tissue Sarcomas.” Presented at Grand Rounds -Orlando Regional Medical Center, April 2005.
“Growth Factor Receptors and Signal Transduction Alteration in Sarcoma.” Presented at the University of South Alabama, April 2005.
“PDGF-R alpha Expression and Activation in Human Sarcoma.” Presented at the 18th Annual Meeting- European Musculosketal Oncology Society, Trieste, Italy, May 2005.
“Application of Linear Cutting Staplers in Resection of Musculosketal Tumors.” Presented at the 18th Annual Meeting- European Musculosketal Oncology Society, Trieste, Italy, May 2005.
“Tumors of Fibrous, Vascular, and Uncertain Lineage.” Presented at the Florida Musculoskeletal Oncology Review, June 2005.
“Soft Tissue Sarcomas and Retroperitoneal Disease.” Presented at Parrish Medical Center. December 2005.
“PDGF-R alpha Expression and Activation in Human Sarcoma.” American Association of Cancer Research. April 2006.
“Soft Tissue Sarcomas of the Extremities and Retroperitoneum.”, Tampa General Hospital, November 2006.
“Cancer Care Economics.”, Florida Hospital Ormond Memorial, May 2007.
“Breast Cancer Surveillance and Recurrence.”, American Cancer Society, Ormond Beach Cancer Care Center, July 2007.
“Pancreatic Cancer”, Gut Club, Daytona Beach FL, 2007.
“Breast Cancer”, Florida Hospital Breast Cancer Symposium, Ormond Beach, FL, October 2007.
“Musculoskeletal Oncology.”, Halifax Hospital Cancer Center, Daytona Beach, FL, January 2008.
“Advances in the Treatment of Extremity Tumors”, Flagler County Medical Society, Halifax Plantation, FL, February 2008.
"Advances in Comprehensive Oncology Care", Florida Hospital Cancer Institue Symposium, Daytona Beach, FL, June 2008.
"Regional Cancer Care Center', Florida Hospital Memorial Foundation, Daytona Beach, FL, December 2008.
"Pancreatic Cancer", Flager County Medical Society, Halifax Plantation, Palm Coast, FL, March 2009.
"Florida Sun: Friend or Foe?", Daytona Beach, FL, April 2009.
"Pancreatic Cancer", Deland Hospital Grand Rounds, Deland, FL, June 2009.
"Cutaneous Malignancies", Premier Group, Daytona Beach, FL, September 2009.
"Advances in Oncology", Comprehensive Oncology Care: Regional Symposium, October, Daytona Beach, FL, 2009.
"Comprehensive Cancer Center and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Surface Malignancies." Florida Hospital Memorial Medical Center, May 2010.
"Peritoneal Surgace Malignancies.", Waterman Hosptial Grand Rounds, Tavares, FL, July 2010.
"Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Surface Malignancies." Florida Hospital Deland, Grand Rounds, Deland, FL, August 2010.
"Florida Hospital Memorial Medical Center Cancer Care Institute: Comprehensive Cancer Center and Clinical Programs." American Cancer Society Board of Directors Conference, Daytona Beach, FL, September 2010.
"Cancer Care Institute" Inaugural Ceremony. Daytona Beach, FL, October 2010.
Copyright 2011 Christopher Windham M.D. - Surgical Oncology. All rights reserved.
Christopher Windham M.D. - Surgical Oncology
Practice: 224 Memorial Medical Parkway
Mailing: 301 Memorial Medical Parkway
Daytona Beach, FL 32117
ph: 386-231-4000
fax: 386-231-4001
TChristo